OUR PRODUCTS

MOBILE APPS

GENERAL INFO

ORIC

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Oric Pharmaceuticals (ORIC) Earnings Date & Reports

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ORIC is expected to report earnings to fall 17.17% to -38 cents per share on November 10

Oric Pharmaceuticals ORIC Stock Earnings Reports

Q3'25

Est.

$-0.39

Q2'25

Missed

by $0.03

Q1'25

Beat

by $0.09

Q4'24

Missed

by $0.01

Q3'24

Missed

by $0.01

The last earnings report on August 12 showed earnings per share of -46 cents, missing the estimate of -43 cents. With 1.18M shares outstanding, the current market capitalization sits at 956.66M.

View a ticker or compare two or three

Compare

ORIC

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ORIC
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ORIC showed earnings on August 12, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a clinical stage company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

240 E. Grand Avenue

Phone

+1 650 388-5600

Employees

100

Web